DK1761514T3 - Hidtil ukendt tetracykliske tetrahydrofuranderivater - Google Patents
Hidtil ukendt tetracykliske tetrahydrofuranderivaterInfo
- Publication number
- DK1761514T3 DK1761514T3 DK05752829T DK05752829T DK1761514T3 DK 1761514 T3 DK1761514 T3 DK 1761514T3 DK 05752829 T DK05752829 T DK 05752829T DK 05752829 T DK05752829 T DK 05752829T DK 1761514 T3 DK1761514 T3 DK 1761514T3
- Authority
- DK
- Denmark
- Prior art keywords
- hitherto unknown
- tetrahydrofuran derivatives
- tetracyclic tetrahydrofuran
- tetracyclic
- derivatives
- Prior art date
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2004051105 | 2004-06-14 | ||
PCT/EP2005/052706 WO2005121113A1 (en) | 2004-06-14 | 2005-06-13 | Novel tetracyclic tetrahydrofuran derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1761514T3 true DK1761514T3 (da) | 2008-12-01 |
Family
ID=34957878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05752829T DK1761514T3 (da) | 2004-06-14 | 2005-06-13 | Hidtil ukendt tetracykliske tetrahydrofuranderivater |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070197525A1 (da) |
EP (1) | EP1761514B1 (da) |
JP (1) | JP2008502649A (da) |
CN (1) | CN1968942B (da) |
AR (1) | AR049512A1 (da) |
AT (1) | ATE402932T1 (da) |
AU (1) | AU2005251948A1 (da) |
CA (1) | CA2567847A1 (da) |
DE (1) | DE602005008596D1 (da) |
DK (1) | DK1761514T3 (da) |
ES (1) | ES2311228T3 (da) |
PL (1) | PL1761514T3 (da) |
PT (1) | PT1761514E (da) |
TW (1) | TW200612899A (da) |
WO (1) | WO2005121113A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ562008A (en) * | 2005-05-26 | 2010-03-26 | Janssen Pharmaceutica Nv | Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
MX388038B (es) | 2008-12-19 | 2025-03-19 | Supernus Pharmaceuticals Inc | Uso de molindona para el tratamiento de agresión. |
MX2012010829A (es) | 2010-03-31 | 2012-11-12 | Supernus Pharmaceuticals Inc | Formulaciones estabilizadas de compuesto para el sistema nervioso central. |
CN103874697A (zh) * | 2011-08-03 | 2014-06-18 | 协和发酵麒麟株式会社 | 二苯并氧杂*衍生物 |
WO2013189920A1 (en) | 2012-06-19 | 2013-12-27 | Ucb Pharma S.A. | New compound based on cinchona alkaloïds for use in asymmetric michael addition |
EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3350405A (en) * | 1964-10-16 | 1967-10-31 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo [a, d] cyclohepten-5-ones and 10, 11-dihydro derivatives thereof |
US3507920A (en) * | 1964-10-16 | 1970-04-21 | Sterling Drug Inc | Hydroxydibenzo(a,d)cyclohepten-5-ones and esters and ethers thereof |
US3565956A (en) * | 1964-10-16 | 1971-02-23 | Sterling Drug Inc | Amino-lower-alkoxy-5-alkylidene-dibenzo(a,d)cycloheptenes |
US3562331A (en) * | 1964-10-16 | 1971-02-09 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo(a,d)cycloheptene-5-carbinols |
US3812119A (en) * | 1969-11-21 | 1974-05-21 | Ciba Geigy Corp | Dibenzocycloheptenes |
CN1116291C (zh) * | 1996-04-12 | 2003-07-30 | 詹森药业有限公司 | 取代的四环四氢呋喃衍生物 |
UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
EP1456193B1 (en) * | 2001-12-07 | 2005-04-27 | Janssen Pharmaceutica N.V. | PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2 i H /i -DIBENZO 3,4:6,7]CYCLOHEPTA 1,2-b]FURAN DERIVATIVES |
-
2005
- 2005-06-13 PT PT05752829T patent/PT1761514E/pt unknown
- 2005-06-13 DE DE602005008596T patent/DE602005008596D1/de not_active Expired - Lifetime
- 2005-06-13 AT AT05752829T patent/ATE402932T1/de active
- 2005-06-13 DK DK05752829T patent/DK1761514T3/da active
- 2005-06-13 WO PCT/EP2005/052706 patent/WO2005121113A1/en active IP Right Grant
- 2005-06-13 CA CA002567847A patent/CA2567847A1/en not_active Abandoned
- 2005-06-13 US US11/570,433 patent/US20070197525A1/en not_active Abandoned
- 2005-06-13 PL PL05752829T patent/PL1761514T3/pl unknown
- 2005-06-13 ES ES05752829T patent/ES2311228T3/es not_active Expired - Lifetime
- 2005-06-13 CN CN2005800194190A patent/CN1968942B/zh not_active Expired - Fee Related
- 2005-06-13 EP EP05752829A patent/EP1761514B1/en not_active Expired - Lifetime
- 2005-06-13 JP JP2007515942A patent/JP2008502649A/ja active Pending
- 2005-06-13 AU AU2005251948A patent/AU2005251948A1/en not_active Abandoned
- 2005-06-13 TW TW094119426A patent/TW200612899A/zh unknown
- 2005-06-13 AR ARP050102402A patent/AR049512A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1968942B (zh) | 2011-06-15 |
EP1761514A1 (en) | 2007-03-14 |
CN1968942A (zh) | 2007-05-23 |
CA2567847A1 (en) | 2005-12-22 |
AR049512A1 (es) | 2006-08-09 |
PL1761514T3 (pl) | 2009-01-30 |
WO2005121113A1 (en) | 2005-12-22 |
AU2005251948A1 (en) | 2005-12-22 |
EP1761514B1 (en) | 2008-07-30 |
DE602005008596D1 (de) | 2008-09-11 |
US20070197525A1 (en) | 2007-08-23 |
ATE402932T1 (de) | 2008-08-15 |
ES2311228T3 (es) | 2009-02-01 |
PT1761514E (pt) | 2008-10-28 |
JP2008502649A (ja) | 2008-01-31 |
TW200612899A (en) | 2006-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
EP1953165A4 (en) | SPIRO AZA-SUBSTITUTED DERIVATIVE | |
DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
ATE540935T1 (de) | Chinazolinderivate | |
DK1809978T3 (da) | Modul-skydebane | |
ATE415400T1 (de) | Pyrazolopyridinderivate | |
ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
EP1717225A4 (en) | BICYCLIC AMIDE DERIVATIVES | |
ATE415385T1 (de) | Hexafluorisopropanolsubstituierte etherderivate | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
DE602004025215D1 (de) | Tastsonde | |
ATE512960T1 (de) | Pyrimidinderivate | |
ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
DE602005012620D1 (de) | Spektroskop | |
ATE387440T1 (de) | Neue 4-benzylidenpiperidinderivate | |
DE602006014973D1 (de) | Neuartige cercosporamidderivate | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
ATE425167T1 (de) | Neue pyridothienopyrimidinderivate | |
DK1761514T3 (da) | Hidtil ukendt tetracykliske tetrahydrofuranderivater | |
DE502005005664D1 (de) | Chronograph | |
ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
DE502005000300D1 (de) | Tastkopf |